Innovating with Integrity

Natera advances molecular diagnostics with integrity and scientific rigor, and supports integration of information provided by our tests into health care decision making. Our tests are clinically validated in over 400 peer-reviewed publications with over 3 million patients studied.

We participated in the largest prospective studies to date in molecular diagnostics in oncology (CIRCULATE), women’s health (SMART), and organ health (Trifecta). We meet or exceed applicable industry and regulatory standards for all of our tests to deliver high-quality results, and have processed over 16 million tests in our CAP/CLIA‑certified labs.

We have more than 150 medical professionals on staff who provide expert support to help make our test results clear and easy to understand.